![]() |
|
|
Vol. 31, Issue 4, 384-391, April 2003
Department of Environmental and Molecular Toxicology, North
Carolina State University, Raleigh, North Carolina
Cytochrome P450 (P450) enzymes are major catalysts involved in the
metabolism of xenobiotics and endogenous substrates such as
testosterone (TST). Major TST metabolites formed by human liver microsomes include 6
-hydroxytestosterone (6
-OHTST),
2
-hydroxytestosterone (2
-OHTST), and 15
-hydroxytestosterone
(15
-OHTST). A screen of 16 cDNA-expressed human P450 isoforms
demonstrated that 94% of all TST metabolites are produced by members
of the CYP3A subfamily with 6
-OHTST accounting for 86% of all TST
metabolites. Similar Km values were observed
for production of 6
-, 2
-, and 15
-OHTST with human liver
microsomes (HLM) and CYP3A4. However, Vmax
and CLint were significantly higher for 6
-OHTST than
2
-OHTST (~18-fold) and 15
-OHTST (~40-fold). Preincubation of
HLM with a variety of ligands, including chemicals used in military
deployments, resulted in varying levels of inhibition or activation of
TST metabolism. The greatest inhibition of TST metabolism in HLM was following preincubation with organophosphorus compounds, including chlorpyrifos, phorate, and fonofos, with up to 80% inhibition noticed
for several metabolites including 6
-OHTST. Preincubation of CYP3A4
with chlorpyrifos, but not chlorpyrifos-oxon, resulted in 98%
inhibition of TST metabolism. Phorate and fonofos also inhibited the
production of most primary metabolites of CYP3A4. Kinetic analysis
indicated that chlorpyrifos was one of the most potent inhibitors of
major TST metabolites followed by fonofos and phorate. Chlorpyrifos,
fonofos, and phorate inhibited major TST metabolites noncompetitively
and irreversibly. Conversely, preincubation of CYP3A4 with
pyridostigmine bromide increased metabolite levels of 6
-OHTST and
2
-OHTST. Preincubation of human aromatase (CYP19) with the test
chemicals had no effect on the production of the endogenous estrogen,
17
-estradiol.
This article has been cited by other articles:
![]() |
B. W. Cooper, T. M. Cho, P. M. Thompson, and A. D. Wallace Phthalate Induction of CYP3A4 is Dependent on Glucocorticoid Regulation of PXR Expression Toxicol. Sci., June 1, 2008; 103(2): 268 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Usmani, T. M. Cho, R. L. Rose, and E. Hodgson Inhibition of the Human Liver Microsomal and Human Cytochrome P450 1A2 and 3A4 Metabolism of Estradiol by Deployment-Related and Other Chemicals Drug Metab. Dispos., September 1, 2006; 34(9): 1606 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Pearce, J. P. Uetrecht, and J. S. Leeder PATHWAYS OF CARBAMAZEPINE BIOACTIVATION IN VITRO: II. THE ROLE OF HUMAN CYTOCHROME P450 ENZYMES IN THE FORMATION OF 2-HYDROXYIMINOSTILBENE Drug Metab. Dispos., December 1, 2005; 33(12): 1819 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Leeder, R. Gaedigk, K. A. Marcucci, A. Gaedigk, C. A. Vyhlidal, B. P. Schindel, and R. E. Pearce Variability of CYP3A7 Expression in Human Fetal Liver J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 626 - 635. [Abstract] [Full Text] [PDF] |
||||